Clinical Trial Update: ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy [Phase 3]

View source ↗

Summary

This is an update on a Phase 3 trial evaluating ASP-1929 photoimmunotherapy for recurrent head and neck cancer in patients who have had at least two prior thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• ASP-1929

Snippet

Sponsor: Rakuten Medical, Inc. | Conditions: Head and Neck Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING